Lurasidone metabolite 14326 hydrochloride

Overview

Lurasidone metabolite 14326 hydrochloride is a minor active metabolite of Lurasidone ( HY-B0032A ) generated via metabolism by CYP3A4 . Lurasidone metabolite 14326 hydrochloride shares similar receptor-binding properties with Lurasidone , acting as an antagonist of the dopamine D2 receptor ( dopamine D2 receptor ), an antagonist of the serotonin 5-HT2A and 5-HT7 receptors ( 5-HT2A and 5-HT7 receptor ), and a partial agonist of the serotonin 5-HT1A receptor. Lurasidone metabolite 14326 hydrochloride can be used in the research of schizophrenia and bipolar depression.

Application

Products | Products > Disease Areas > Depression | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Schizophrenia | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Drug Metabolite | Products > Signaling Pathways > Dopamine Receptor | Products > Signaling Pathways > 5-HT Receptor

Product Information

• Catalog No.: HY-G0002A
• CAS No.: 2446700-69-0
• Molecular Formula: C28H37ClN4O3S
• Molecular Weight: 545.14
• Purity: 99.42%
• Storage: -20°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 1.25 mg/mL (2.29 mM); Clear solution
• Availability: In-stock

Source

Original product source